Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Calfactant in Spontaneously Breathing RDS Patients
NCT03058666Phase 3Completed
- Start
- Mar 2017
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of calfactant in respiratory distress syndrome (RDS). Started Mar 2017; status: completed.
02
Drugs
calfactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT03058666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058666.